# ORCHPHARMA — Orchid Pharma Limited

> Orchid Pharma Limited (ORCHPHARMA) on the NSE: 1,437 sessions of split-adjusted history from 2020.

Canonical: https://patternsradar.com/s/ORCHPHARMA

## Latest session

- Close: 1,002.05 INR (2.24% on the day), 2026-08-21
- Delivery: 72.29% of volume taken to demat (20-day average 46.61%)
- Volume: 1.06L shares, turnover ₹10.6Cr
- Relative volume: 1.38× of its own 20-day average

## Technicals

- RSI(14): 49.91
- ATR(14): 48.07
- SMA 50: 1,001.9, SMA 200: 776.74
- 52-week range: 480 – 1,133 (-11.56% from the high)

## Performance

- 1 week -4.17%, 1 month 4.11%, 3 months 41.83%
- 6 months 50.93%, 1 year 30.46%

## Fundamentals

- Market cap: 5,082.3 crore
- P/E (TTM): 586.36 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 1.71 INR, split-adjusted to match the price series
- Revenue growth: 75.89% YoY, 28.01% QoQ
- Profit growth: -78.38% YoY, -86.44% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 3.44% | -72.12% |
| 3y | 9.5% | -50.33% |
| 4y | 12.04% | -11.2% |
| 5y | 17.37% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 222.7 | 204.3 | 25.9 | 27.2 | 5.37 | 12.23% |
| 2024-12-31 | 217.3 | 203.4 | 22.5 | 20.8 | 4.1 | 9.56% |
| 2025-03-31 | 237.5 | 222.3 | 19.1 | 22.3 | 4.4 | 9.39% |
| 2025-06-30 | 172.9 | 170.7 | 13.7 | 14.9 | 2.94 | 8.62% |
| 2025-09-30 | 193.5 | 207.6 | -3.3 | -5.7 | -1.13 | -2.96% |
| 2025-12-31 | 207.3 | 217.9 | -12.1 | -12.6 | -2.49 | -6.09% |
| 2026-03-31 | 368.3 | 351 | 24.8 | 25.8 | 4.31 | 7.02% |
| 2026-06-30 | 304.2 | 303.4 | 2.6 | 3.2 | 0.54 | 1.06% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 69.84%
- Public: 30.16%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-14: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_187743_14082026201929_iXBRL_WEB.html
- 2026-07-21: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1698756_21072026070731_WEB.xml
- 2026-05-25: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_161077_25052026221314_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1655372_20042026063250_WEB.xml
- 2026-02-11: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142171_11022026203716_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1606996_21012026034245_WEB.xml
- 2025-11-11: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_126202_11112025192744_iXBRL_WEB.html
- 2025-10-18: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1553451_18102025032101_WEB.xml

Dated by the day the company broadcast the filing. 51 events are indexed for this instrument.

## About the instrument

- Listed: 2020-11-03 — latest session 2026-08-21 (1,437 sessions)
- ISIN: INE191A01027
- Series: EQ
- Liquidity rank: #1093 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/ORCHPHARMA.